Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2016, Article ID 6217135, 8 pages
http://dx.doi.org/10.1155/2016/6217135
Research Article

Dialysate White Blood Cell Change after Initial Antibiotic Treatment Represented the Patterns of Response in Peritoneal Dialysis-Related Peritonitis

1Division of Clinical Epidemiology, Faculty of Medicine, Thammasat University, Rangsit Campus, Pathum Thani, Thailand
2Division of Nephrology, Department of Medicine, Thammasat University Hospital, Pathum Thani, Thailand
3Banphaeo Hospital, Prommitr Branch, Bangkok, Thailand

Received 19 June 2016; Accepted 3 August 2016

Academic Editor: Francesca Mallamaci

Copyright © 2016 Pichaya Tantiyavarong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Piraino, “Peritonitis as a complication of peritoneal dialysis,” Journal of the American Society of Nephrology, vol. 9, no. 10, pp. 1956–1964, 1998. View at Google Scholar · View at Scopus
  2. T. N. Oo, T. L. Roberts, and A. J. Collins, “A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients,” American Journal of Kidney Diseases, vol. 45, no. 2, pp. 372–380, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. M. C. Brown, K. Simpson, J. J. Kerssens, and R. A. Mactier, “Peritoneal dialysis-associated peritonitis rates and outcomes in a national cohort are not improving in the post-millennium (2000–2007),” Peritoneal Dialysis International, vol. 31, no. 6, pp. 639–650, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Dhanakijcharoen, D. Sirivongs, S. Aruyapitipan, P. Chuengsaman, and A. Lumpaopong, “The ‘PD First’ policy in Thailand: three-years experiences (2008–2011),” Journal of the Medical Association of Thailand, vol. 94, supplement 4, pp. S153–S161, 2011. View at Google Scholar · View at Scopus
  5. Y. Cho, S. V. Badve, C. M. Hawley et al., “Seasonal variation in peritoneal dialysis-associated peritonitis: a multi-centre registry study,” Nephrology, Dialysis, Transplantation, vol. 27, no. 5, pp. 2028–2036, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Piraino, G. R. Bailie, J. Bernardini et al., “Peritoneal dialysis-related infections recommendations: 2005 update,” Peritoneal Dialysis International, vol. 25, no. 2, pp. 107–131, 2005. View at Google Scholar
  7. M. Krishnan, E. Thodis, D. Ikonomopoulos et al., “Predictors of outcome following bacterial peritonitis in peritoneal dialysis,” Peritoneal Dialysis International, vol. 22, no. 5, pp. 573–581, 2002. View at Google Scholar · View at Scopus
  8. C.-C. Szeto, K.-M. Chow, T. Y.-H. Wong et al., “Feasibility of resuming peritoneal dialysis after severe peritonitis and Tenckhoff catheter removal,” Journal of the American Society of Nephrology, vol. 13, no. 4, pp. 1040–1045, 2002. View at Google Scholar · View at Scopus
  9. K. M. Chow, C. C. Szeto, K. K.-T. Cheung et al., “Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis,” Clinical Journal of the American Society of Nephrology, vol. 1, no. 4, pp. 768–773, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. P. K.-T. Li, C. C. Szeto, B. Piraino et al., “Peritoneal dialysis-related infections recommendations: 2010 update,” Peritoneal Dialysis International, vol. 30, no. 4, pp. 393–423, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. G. E. Digenis, G. Abraham, E. Savin et al., “Peritonitis-related deaths in continuous ambulatory peritoneal dialysis (CAPD) patients,” Peritoneal Dialysis International, vol. 10, no. 1, pp. 45–47, 1990. View at Google Scholar · View at Scopus
  12. J. Dong, Z. Li, R. Xu, Y. Chen, S. Luo, and Y. Li, “Disease severity score could not predict the outcomes in peritoneal dialysis-associated peritonitis,” Nephrology Dialysis Transplantation, vol. 27, no. 6, pp. 2496–2501, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Scharfer, G. Klaus, D. E. Müller-Wiefel, and O. Mehls, “Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS),” Journal of the American Society of Nephrology, vol. 10, no. 1, pp. 136–145, 1999. View at Google Scholar · View at Scopus
  14. R. Xu, Y. Chen, S. Luo et al., “Clinical characteristics and outcomes of peritoneal dialysis-related peritonitis with different trends of change in effluent white cell count: A Longitudinal Study,” Peritoneal Dialysis International, vol. 33, no. 4, pp. 436–444, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. J. A. Quintanar Lartundo, R. Palomar, A. Dominguez-Diez et al., “Microbiological profile of peritoneal dialysis peritonitis and predictors of hospitalization,” Advances in Peritoneal Dialysis, vol. 27, pp. 38–42, 2011. View at Google Scholar · View at Scopus
  16. C.-C. Szeto, K.-M. Chow, B. C.-H. Kwan et al., “Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 2, pp. 245–251, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Govindarajulu, C. M. Hawley, S. P. Mcdonald et al., “Staphylococcus Aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases,” Peritoneal Dialysis International, vol. 30, no. 3, pp. 311–319, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. S. O'Shea, C. M. Hawley, S. P. McDonald et al., “Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases,” BMC Nephrology, vol. 10, no. 1, article 19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Edey, C. M. Hawley, S. P. McDonald et al., “Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases,” Nephrology Dialysis Transplantation, vol. 25, no. 4, pp. 1272–1278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. C.-C. Szeto, K.-M. Chow, C.-B. Leung et al., “Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases,” Kidney International, vol. 59, no. 6, pp. 2309–2315, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Siva, C. M. Hawley, S. P. McDonald et al., “Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 5, pp. 957–964, 2009. View at Publisher · View at Google Scholar · View at Scopus